GGrantIndex
Sort

23,748 grants matching melanoma

Cancer Biology in the Zebrafish

$420,375
Leonard I Zon · Boston Children'S Hospital · R01 · FY2018 · CA

Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array

$420,331
Margaret Elisabeth Huflejt · New York University School Of Medicine · U01 · FY2010 · CA

Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death

$420,313
Clifford Cho · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification

$420,270
David M. Ashley · Duke University · U19 · FY2025 · CA

Encapsulated Cell Based Oncolytic Virus Therapy for Brain Tumors

$420,251
Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2025 · NS

Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy

$419,793
Song Li · University Of California Los Angeles · R01 · FY2020 · CA

THE MITOCHONDRIAL UNFOLDED PROTEIN RESPONSE IMPACTS MELANOMA FROM INITIATION TO PATIENT PROGNOSIS

$419,751
Icahn School Of Medicine At Mount Sinai · · FY2022 · Defense Health Agency

Novel Immunologic Effects of Semaphorin 7a in IPF

$419,743
Erica L Herzog · Yale University · R01 · FY2011 · HL

Developmental Funds

$419,586
Dario C. Altieri · Wistar Institute · P30 · FY2019 · CA

T cell-intrinsic metabolic control of radiotherapy

$419,461
Lewis Zhichang Shi · University Of Alabama At Birmingham · R01 · FY2024 · CA

T cell-intrinsic metabolic control of radiotherapy

$419,461
Lewis Zhichang Shi · University Of Alabama At Birmingham · R01 · FY2025 · CA

Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature

$419,449
Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA

Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia

$419,407
Kevin M Shannon · Indiana University Indianapolis · U54 · FY2017 · CA

Function and Regulation of the BCL-2 Family

$419,374
Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

Using Nonclassical Estrogen Signaling to Prevent Melanoma

$419,353
Todd W Ridky · University Of Pennsylvania · R01 · FY2023 · CA

Role of Formylpeptide Receptors in Host Defense

$419,275
Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Using dietary glutamine supplementation for melanoma prevention and targeted therapy

$419,220
Mei Kong · University Of California-Irvine · R01 · FY2022 · CA

Targeting the Rac1 signaling pathway in malignant melanoma

$419,207
Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · R01 · FY2022 · CA

EGFRvIII-targeted Bispecific T cell Engagers for brain tumors

$419,152
John H Sampson · Duke University · R01 · FY2014 · NS

Tpl2 in carcinogenesis-related inflammation

$419,137
Kathleen Leigh Decicco-Skinner · American University · R15 · FY2015 · CA

Leveraging combination histotripsy tumor ablation and N-dihydrogalactochitosan immunostimulation to advance osteosarcoma therapy

$419,080
Joanne Tuohy · Virginia Polytechnic Inst And St Univ · R21 · FY2025 · CA

Role of PTPRT in colon cancer progression and metastasis

$418,930
Zhenghe Wang · Case Western Reserve University · R01 · FY2024 · CA

Impact of senescence on T-cell function and immunotherapeutic response

$418,905
Christin E Burd · Ohio State University · R01 · FY2018 · AG

Impact of senescence on T-cell function and immunotherapeutic response

$418,905
Christin E Burd · Ohio State University · R01 · FY2019 · AG

ISG15 and Protein ISGylation in Cancer

$418,800
Dong-Er Zhang · University Of California, San Diego · R01 · FY2019 · CA